Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  British heart journal

• Publication date

  1993-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/hrt.70.4.363PMID 8217446PMCID PMC1025333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Level and diurnal variations of hormones of interest to the cardiovascular system in patients with heart transplants.

  1992cited by this paper
• Vasoactive intestinal peptide fluctuates in human blood with a circadian rhythm.

  1991cited by this paper
• Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.

  1990cited by this paper
• Immunohistochemical demonstration of human cardiac innervation before and after transplantation.

  1990cited by this paper
• Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.

  1990cited by this paper
• Effect of cyclosporine on atrial natriuretic factor in patients with uveitis.

  1990cited by this paper
• The effect of oral glucose, protein, fat and water loading on blood pressure and the gastrointestinal peptides VIP and somatostatin in hypertensive elderly subjects

  1990cited by this paper
• Synergistic hypotensive effect of vasoactive intestinal polypeptide and alpha-blockade with phentolamine. Evidence for vasoactive intestinal peptide alpha-adrenoceptor coupling in the cardiovascular system of newborn dogs.

  1990cited by this paper
• Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles.

  1989cited by this paper
• Synthesis and secretion of vasoactive intestinal peptide by rat fetal cerebral cortical and hypothalamic cells in culture.

  1989cited by this paper
• Coronary hemodynamic effects of intravenous vasoactive intestinal peptide in humans.

  1989cited by this paper
• Effect of cyclosporine on glucose metabolism in kidney transplant recipients.

  1988cited by this paper
• Neurotensin and vasoactive intestinal peptide levels during orthotopic liver transplantation in man.

  1988cited by this paper
• The long-term course of cyclosporine-associated chronic nephropathy.

  1988cited by this paper
• Effects of neurotensin, vasoactive intestinal peptide and substance P on plasma immunoreactive atrial natriuretic factor in rats

  1987cited by this paper
• Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.

  1987cited by this paper
• Cardiovascular effects of vasoactive intestinal peptide in healthy subjects.

  1987cited by this paper
• Vasoactive intestinal peptide: a direct renal natriuretic substance.

  1987cited by this paper
• Peptidergic innervation of human atrial myocardium: an electron microscopical and immunocytochemical study.

  1986cited by this paper
• Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

  1986cited by this paper
• Raised concentrations of plasma atrial natriuretic peptides in cardiac transplant recipients.

  1986cited by this paper
• Cyclosporine nephrotoxicity: pathogenesis, prophylaxis, therapy, and prognosis.

  1986cited by this paper
• Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.

  1985cited by this paper
• Effect of cyclosporine administration on renal hemodynamics in conscious rats.

  1985cited by this paper
• Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.

  1984cited by this paper
• Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart

  1984cited by this paper
• Regulatory peptides (SP, NT, VIP, PHI, ENK) of autonomic nerves in the guinea pig heart.

  1984cited by this paper
• Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter.

  1984cited by this paper
• The distribution and morphological characteristics of the intracortical VIP-positive cell: an immunohistochemical analysis.

  1984cited by this paper
• Vasoactive intestinal polypeptide and somatostatin in leucocytes.

  1984cited by this paper
• Neuropeptides contained in peripheral cardiovascular nerves.

  1984cited by this paper
• Vasoactive intestinal polypeptide-immunoreactive nerves in the kidney.

  1983cited by this paper
• Vasoactive intestinal peptide in shock and heart failure.

  1983cited by this paper
• A new neuroregulator: the vasoactive intestinal peptide or VIP.

  1982cited by this paper
• Effect of cyclosporin on renin-angiotensin-aldosterone system.

  1982cited by this paper
• Inferential statistical methods for estimating and comparing cosinor parameters.

  1982cited by this paper
• The gut hormone profile of fulminant hepatic failure.

  1981cited by this paper
• Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes.

  1980cited by this paper
• Neural release of vasoactive intestinal peptide from the gut.

  1980cited by this paper
• Neural Release of Vasoactive Intestinal Peptide from the Gut

  1980cited by this paper
• Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function.

  1979cited by this paper
• Peptides as neurotransmitter candidates in the mammalian cns

  1979cited by this paper
• Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: evidence from combined immunohistochemistry and acetylcholinesterase staining.

  1979cited by this paper
• Approaches towards rational antiviral chemotherapy.

  1979cited by this paper
• Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

  1976cited by this paper
• Circadian System Phase — An Aspect of Temporal Morphology; Procedures and Illustrative Examples

  1967cited by this paper

• The Cardiac Circadian Proteome and Transcriptome: a Novel Paradigm Characterizing Cardiovascular Health and Disease

  2014cites this paper
• Circadian Proteomics and Its Unique Advantage for Discovery of Biomarkers of Heart Disease

  2012cites this paper
• Vasoactive Intestinal Peptide

  2006cites this paper
• Effect of Sodium Depletion by Frusemide on Tissue Concentrations and Metabolism of VIP a

  1998influential citation
• Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels.

  1998cites this paper
• Diurnal changes in cyclosporine effect on ornithine decarboxylase and noradrenergic and cholinergic activities in submaxillary lymph nodes.

  1997cites this paper
• Effect of age and relation to mortality on serial changes of vasoactive intestinal peptide in acute myocardial infarction.

  1996cites this paper
• Long term effects of ritodrine on blood pressure and heart rate of adolescents exposed during the prenatal stage.

  1995cites this paper